Hydreight Delivers Record First Quarter 2026 Revenue of $24.9 Million with 449% Revenue Growth, $3.3 Million in Adjusted EBITDA² and $32.0 Million in Working Capital
Hydreight Technologies reported Q1 2026 results for the three months ended March 31, 2026: revenue rose to $24.9 million from $4.5 million (+449% YoY). Adjusted EBITDA was $3.3 million versus $0.2 million a year earlier, and net income was $2.6 million. The company ended the quarter with $24.2 million cash and $32.0 million working capital, according to its release.
How this was made
The 30-second read
Why it matters
Q1 results show accelerating top-line growth, expanding Adjusted EBITDA margin, and strengthened liquidity, which can shift valuation expectations and improve perceived execution risk.
Market read
Traders can use the printed Q1 datapoints (revenue, Adjusted EBITDA, margin, cash/working capital) to reassess near-term fundamentals and momentum into subsequent quarters.
What to watch
No disclosure here of customer concentration, churn/retention, cash conversion details, or full-year guidance specifics—these can materially affect whether the market sustains the rerating.
Background
Hydreight is a U.S.-focused digital health infrastructure platform scaling its provider network, pharmacy operations, and its VSDHOne technology/compliance offering.
Ticker impact
Hydreight reported record Q1 2026 revenue of $24.9M (+449% YoY) and Adjusted EBITDA of $3.3M, alongside $24.2M cash and $32.0M working capital.
Near-term positive bias; magnitude depends on how the market had priced prior growth and whether full-year guidance is credible.
The article provides multiple concrete datapoints (revenue, Adjusted EBITDA, net income, cash/working capital) but does not include explicit full-year guidance numbers or consensus comparisons, limiting precision on incremental upside.
Market effects
Reinforces demand for compliant healthcare infrastructure/telehealth-adjacent platforms and could improve sentiment toward digital health infrastructure operators.
Primarily U.S.-focused operations; limited direct regional spillover beyond U.S. small/micro-cap digital health.
Low—company is not broadly systemically relevant; impact likely confined to small-cap healthcare infrastructure peers.
Counterpoint
Adjusted metrics (Adjusted Revenue/Adjusted EBITDA) may mask underlying IFRS revenue recognition and recurring profitability quality; growth could be partly driven by transaction-volume mechanics.
Key entities
- companyHydreight Technologies Inc.
Reported Q1 2026 record revenue, Adjusted EBITDA, net income, and improved cash/working capital; reiterated momentum toward full-year 2026 guidance.
- product_platformVSDHOne
Hydreight’s platform offering intended to reduce barriers for compliant healthcare brand launches; company is investing in VSDHOne 2.0 and workflow tech.
- partnerVictory Square Technologies
Named as a partnership partner in the development of VSDHOne.
